38112003: un (valeur de l'attribut)

SNOMED CT Concept\valeur de l'attribut\nombre\un

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	est un(e) (attribut)	modificateur adjectival général	false	Inferred relationship	Some
un	est un(e) (attribut)	nombre	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Somatropin(rbe) 2 mg powder for solution for injection syringe	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Somatropin(rbe) 2 mg powder for solution for injection syringe	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely somatropin(rbe) 24 milligram/1 cartridge powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely somatropin(rbe) 24 milligram/1 cartridge powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Trihexyphenidyl hydrochloride 1 mg/mL oral solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely hexastarch 60 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely somatropin(rmc) 1.33 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely somatropin(rmc) 1.33 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Sodium citrate 4 g granules for oral solution sachet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Sodium citrate 4 g granules for oral solution sachet	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely imipramine hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Trimethoprim 10 mg/mL oral suspension	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Trimethoprim 10 mg/mL oral suspension	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely teicoplanin 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely teicoplanin 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely prednisolone 1 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Mefenamic acid 10 mg/mL oral suspension	Count of base of active ingredient	False	un	Inferred relationship	Some
Somatropin(rmc) 3.33 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Somatropin(rmc) 3.33 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely teicoplanin 400 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely teicoplanin 400 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely prednisolone 3 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely periciazine 2 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Rifampin 20 mg/mL oral suspension	Count of base of active ingredient	False	un	Inferred relationship	Some
Interferon alfa-2b 1 million unit powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Interferon alfa-2b 1 million unit powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Interferon alfa-2b 1 million unit powder for solution for injection vial	Has presentation strength numerator value (attribute)	False	un	Inferred relationship	Some	1
Product containing precisely sargramostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely sargramostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Spiramycin 25 mg/mL oral solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely tenoxicam 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely tenoxicam 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely tramadol hydrochloride 100 milligram/1 sachet effervescent powder for conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely tramadol hydrochloride 100 milligram/1 sachet effervescent powder for conventional release oral solution (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely etanercept 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely etanercept 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Zidovudine 10 mg/mL oral solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely felbamate 120 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely indometacin (as indometacin sodium trihydrate) 1 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely indometacin (as indometacin sodium trihydrate) 1 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely indometacin (as indometacin sodium trihydrate) 1 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value (attribute)	False	un	Inferred relationship	Some	1
ticarcilline 3 g/acide clavulanique 200 mg, fiole de poudre pour perfusion (médicament clinique)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
ticarcilline 3 g/acide clavulanique 200 mg, fiole de poudre pour perfusion (médicament clinique)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Dexamethasone 100 microgram/mL oral solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Peginterferon alfa-2b 50 microgram powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Peginterferon alfa-2b 50 microgram powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ispaghula husk 3.5 gram/1 sachet granules for conventional release oral suspension (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ispaghula husk 3.5 gram/1 sachet granules for conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Epirubicin hydrochloride 20 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Epirubicin hydrochloride 20 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Coagulation factor XIII 1250 unit powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Coagulation factor XIII 1250 unit powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Ispaghula husk 6 g powder for oral suspension sachet	Count of base of active ingredient	False	un	Inferred relationship	Some
Ispaghula husk 6 g powder for oral suspension sachet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely coagulation factor XIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely coagulation factor XIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial	Has presentation strength numerator value (attribute)	False	un	Inferred relationship	Some	1
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Peginterferon alfa-2b 120 microgram powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Peginterferon alfa-2b 120 microgram powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Trastuzumab 150 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Trastuzumab 150 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely calcium phosphate 3.3 gram/1 sachet powder for conventional release oral suspension (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely calcium phosphate 3.3 gram/1 sachet powder for conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Pentostatin 10 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Pentostatin 10 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value (attribute)	False	un	Inferred relationship	Some	1
Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
ganciclovir 500 mg, fiole de poudre pour perfusion (médicament clinique)	Count of base of active ingredient	False	un	Inferred relationship	Some
ganciclovir 500 mg, fiole de poudre pour perfusion (médicament clinique)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely gonadorelin (as gonadorelin hydrochloride) 100 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely gonadorelin (as gonadorelin hydrochloride) 100 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely molgramostim 150 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely molgramostim 150 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
floxacilline 250 mg, fiole de poudre pour solution injectable (médicament clinique)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
floxacilline 250 mg, fiole de poudre pour solution injectable (médicament clinique)	Count of base of active ingredient	False	un	Inferred relationship	Some

Start Previous Page 186 of 217 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
615211000077111	un (valeur de l'attribut)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core